Literature DB >> 10692096

Antibodies to human papillomavirus type 5 are generated in epidermal repair processes.

M Favre1, S Majewski, B Noszczyk, F Maienfisch, A Pura, G Orth, S Jablonska.   

Abstract

We reported previously that patients with psoriasis harbored at a very high frequency DNA sequences of the oncogenic human papillomavirus type 5 (HPV5) associated with epidermodysplasia verruciformis. Moreover anti-HPV5 antibodies were detected in 25% of the cases. Our aim was to find out whether keratinocyte hyperproliferation and/or autoimmunity could be responsible for HPV5 expression in psoriasis. We found that epidermal repair in patients with extensive second degree burns (n = 19) is frequently associated with the generation of anti-HPV5 antibodies. In patients with autoimmune bullous diseases (n = 118), a condition in which keratinocyte proliferation is involved in repair mechanisms, the prevalence of anti-HPV5 antibodies (15%-25%) was similar to that reported in psoriasis and significantly higher than that (5%) observed in individuals with no known history of human papillomavirus infection (n = 119). A high detection rate (57.9%) of HPV5 DNA was observed in patients with bullous diseases. Anti-HPV5 antibodies were found in patients with autoimmune connective tissue disorders with cutaneous involvement (n = 40) as frequently as in patients with bullous diseases. HPV5 DNA was detected in one of the 10 patients studied. In contrast, the prevalence of anti-HPV5 antibodies in patients with autoimmune neurological disorders (n = 47) and in patients with common warts (n = 28) or invasive carcinomas of the skin (n = 40) was as low as in the general population. It is worth stressing that a similar prevalence of antibodies against HPV1 was found in all groups studied. Our data strongly suggest that extensive keratinocyte proliferation is a major factor for the generation of anti-HPV5 antibodies and that autoimmunity may contribute to this phenomenon. It remains to be determined whether HPV5 and other human papillomavirus genotypes associated with epidermodysplasia verruciformis contribute to the hyperproliferation of keratinocytes occurring in epidermal repair and in psoriasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692096     DOI: 10.1046/j.1523-1747.2000.00892.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Epidermodysplasia verruciformis defines a subset of cutaneous human papillomaviruses.

Authors:  G Orth; M Favre; S Majewski; S Jablonska
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  [Biology of epidermodysplasia verruciformis-associated HPV].

Authors:  H Pfister
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

3.  Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis.

Authors:  Mathieu Nonnenmacher; Jérôme Salmon; Yves Jacob; Gérard Orth; Françoise Breitburd
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Serological relationship between cutaneous human papillomavirus types 5, 8 and 92.

Authors:  Alessandra Handisurya; Ratish Gambhira; Christina Schellenbacher; Saeed Shafti-Keramat; Ola Forslund; Michel Favre; Reinhard Kirnbauer
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

Review 5.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

6.  Beta-papillomaviruses and psoriasis: an intra-patient comparison of human papillomavirus carriage in skin and hair.

Authors:  J G Cronin; D Mesher; K Purdie; H Evans; J Breuer; C A Harwood; J M McGregor; C M Proby
Journal:  Br J Dermatol       Date:  2008-07-01       Impact factor: 9.302

7.  HPV-47-Induced and Tattoo-associated Verrucae Planae: Report of a Case and Review of the Literature.

Authors:  Nathalie Krecké; Sigrun Smola; Thomas Vogt; Cornelia Sigrid Lissi Müller
Journal:  Dermatol Ther (Heidelb)       Date:  2017-08-23

8.  Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: a case-control study in Uganda.

Authors:  Maurits Nc de Koning; Keith Waddell; Joseph Magyezi; Karin Purdie; Charlotte Proby; Catherine Harwood; Sebastian Lucas; Robert Downing; Wim Gv Quint; Robert Newton
Journal:  Infect Agent Cancer       Date:  2008-09-10       Impact factor: 2.965

9.  Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses.

Authors:  Maciej Lazarczyk; Christian Pons; José-Andrès Mendoza; Patricia Cassonnet; Yves Jacob; Michel Favre
Journal:  J Exp Med       Date:  2007-12-24       Impact factor: 14.307

10.  Seroprevalence of 34 human papillomavirus types in the German general population.

Authors:  Kristina M Michael; Tim Waterboer; Peter Sehr; Annette Rother; Ulrich Reidel; Heiner Boeing; Ignacio G Bravo; Jörg Schlehofer; Barbara C Gärtner; Michael Pawlita
Journal:  PLoS Pathog       Date:  2008-06-20       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.